ANVISA registration 81472060046Valid until Jul 28, 2035

STREPTOCOCCUS

Name: STREPTOCOCCUS — ANVISA registration 81472060046
Creator: HANGZHOU AICHEK MEDICAL TECHNOLOGY CO., LTD.
Keywords: STREPTOCOCCUS, STREPTOCOCCUS, Teste Rápido de Antígeno Strep A, 81472060046, Risk Class III, ANVISA registration

ANVISA Registration Number: 81472060046ADVAGEN BIOTECH LTDAHANGZHOU AICHEK MEDICAL TECHNOLOGY CO., LTD.Risk Class III

Verified

Device names

Technical name: STREPTOCOCCUS
Commercial name: Teste Rápido de Antígeno Strep A
Risk class: Class III

Registration details

Registration Number: 81472060046
Process Number: 25351443067202461
CNPJ: 22565307000172

Company information

Registration Holder: ADVAGEN BIOTECH LTDA
Manufacturer: HANGZHOU AICHEK MEDICAL TECHNOLOGY CO., LTD.
Manufacturing Country: China

Dates and status

Publication Date: Jul 28, 2025
Validity: 28/07/2035
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for STREPTOCOCCUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81472060046 and manufactured by HANGZHOU AICHEK MEDICAL TECHNOLOGY CO., LTD.. The registration is held by ADVAGEN BIOTECH LTDA with validity until Jul 28, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.